Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database
Surgery Today · 2026-11 · 56 (11) · 2772-2781
DOI: 10.1007/s00595-026-03389-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 20.07.2026. Verfasst von Taisuke Kaiho und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biliary Tract Neoplasms, Lung Neoplasms, Metastasectomy. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Pancreatic carcinoma (PC) and biliary tract carcinoma (BTC) may metastasize to the lungs, and surgical resection of these metastases should be considered in selected patients with controlled primary disease. This study evaluated the survival outcomes and prognostic factors in patients who underwent pulmonary metastasectomy for pancreatobiliary carcinoma.
Methods
Seventy-eight patients who underwent lung metastasectomy between 1993 and 2019 were included in the Metastatic Lung Tumor Study Group of the Japan database. The clinicopathological characteristics including overall survival (OS), pulmonary metastasis-free survival (PmFS), and disease-free interval (DFI) from primary surgery to lung metastasectomy were analyzed.
Results
We included 41 men and 37 women with a mean age of 67 years. The primary cancers included 56 PC and 22 BTC cases. Partial resection was performed in 52 patients, segmentectomy in 16, and lobectomy in 10. Five-year OS was 38.3% (43.2% for PC and 28.1% for BTC). Five-year PmFS was 28.3% (28.4% for PC and 27.7% for BTC). The median DFI was 36.0 months (21.0–47.5 months, interquartile range). Larger metastases (> 2 cm) were significantly associated with a poorer survival (hazard ratio, 2.03; 95% confidence interval, 1.06–3.90, p = 0.03).
Conclusion
Lung metastasectomy may be a viable treatment option for select patients with pancreatobiliary carcinoma, particularly those with smaller metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
- Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan. hidemisuzukidesu@yahoo.co.jp.
- Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
- Department of Thoracic Surgery, Aichi Cancer Center, Aichi, Japan.
- Department of Thoracic Surgical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
- Department of Thoracic Surgery, National Defense Medical College, Saitama, Japan.
Zitieren
APA
Kaiho, T., Toyoda, T., Suzuki, H., Yamauchi, Y., Sakakura, N., Mun, M., Hashimoto, H., Iwata, T., Shintani, Y., Chida, M., Matsuguma, H., Asakura, K., Endo, M., Iida, T., Kohno, M., Kondo, H., Ikeda, N., Sato, M., Sakao, Y., & Metastatic Lung Tumor Study Group of Japan (METAL-J) (2026). Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database. Surgery Today, 56(11), 2772-2781. https://doi.org/10.1007/s00595-026-03389-8
Vancouver
Kaiho T, Toyoda T, Suzuki H, Yamauchi Y, Sakakura N, Mun M, et al. Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database. Surgery Today. 2026;56(11):2772-2781. doi:10.1007/s00595-026-03389-8
BibTeX
@article{Kaiho2026,
author = {Kaiho, Taisuke and Toyoda, Takahide and Suzuki, Hidemi and Yamauchi, Yoshikane and Sakakura, Noriaki and Mun, Mingyon and Hashimoto, Hiroshi and Iwata, Takekazu and Shintani, Yasushi and Chida, Masayuki and Matsuguma, Haruhisa and Asakura, Keisuke and Endo, Makoto and Iida, Tomohiko and Kohno, Mitsutomo and Kondo, Haruhiko and Ikeda, Norihiko and Sato, Masaaki and Sakao, Yukinori and Metastatic Lung Tumor Study Group of Japan (METAL-J), Metastatic Lung Tumor Study Group of Japan (METAL-J)},
title = {Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {11},
pages = {2772--2781},
doi = {10.1007/s00595-026-03389-8}
}
EUVIMED